DZ3096A1 - Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés. - Google Patents

Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.

Info

Publication number
DZ3096A1
DZ3096A1 DZ000144A DZ000144A DZ3096A1 DZ 3096 A1 DZ3096 A1 DZ 3096A1 DZ 000144 A DZ000144 A DZ 000144A DZ 000144 A DZ000144 A DZ 000144A DZ 3096 A1 DZ3096 A1 DZ 3096A1
Authority
DZ
Algeria
Prior art keywords
düpyrimidine
pyridylsulfonyl
derivatives
preparation
intermediates used
Prior art date
Application number
DZ000144A
Other languages
English (en)
Inventor
Keith Michael Devries
Philip Charles Levett
Joanna Teresa Negn
Albert Shaw Wood
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9924042.6A external-priority patent/GB9924042D0/en
Priority claimed from GB0018667A external-priority patent/GB0018667D0/en
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ3096A1 publication Critical patent/DZ3096A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
DZ000144A 1999-10-11 2000-10-10 Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés. DZ3096A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9924042.6A GB9924042D0 (en) 1999-10-11 1999-10-11 Process for thr preparation of pyrazolo[4,3-D]pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
GB0018667A GB0018667D0 (en) 2000-07-28 2000-07-28 Process for the preparation of pyrazolo [4,3-d] Pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
DZ3096A1 true DZ3096A1 (fr) 2004-06-20

Family

ID=26244761

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ000144A DZ3096A1 (fr) 1999-10-11 2000-10-10 Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.

Country Status (39)

Country Link
EP (1) EP1092720B1 (fr)
JP (1) JP2001114783A (fr)
KR (1) KR100395718B1 (fr)
CN (1) CN1292379A (fr)
AR (1) AR029767A1 (fr)
AT (1) ATE286899T1 (fr)
AU (1) AU6543600A (fr)
BG (1) BG104840A (fr)
BR (1) BR0004787A (fr)
CA (1) CA2322995A1 (fr)
CO (1) CO5251476A1 (fr)
CZ (1) CZ20003754A3 (fr)
DE (1) DE60017330D1 (fr)
DZ (1) DZ3096A1 (fr)
EA (1) EA003145B1 (fr)
EE (1) EE200000537A (fr)
EG (1) EG22775A (fr)
GT (1) GT200000169A (fr)
HR (1) HRP20000674A2 (fr)
HU (1) HUP0003979A3 (fr)
ID (1) ID27539A (fr)
IL (1) IL138913A0 (fr)
IN (1) IN190477B (fr)
IS (1) IS5654A (fr)
MA (1) MA25867A1 (fr)
MX (1) MXPA00009936A (fr)
NO (1) NO316072B1 (fr)
NZ (1) NZ507431A (fr)
OA (1) OA11495A (fr)
PA (1) PA8504601A1 (fr)
PE (1) PE20010682A1 (fr)
PL (1) PL343140A1 (fr)
SG (1) SG97950A1 (fr)
SK (1) SK15052000A3 (fr)
SV (1) SV2002000194A (fr)
TN (1) TNSN00195A1 (fr)
TR (1) TR200002959A2 (fr)
UY (1) UY26388A1 (fr)
YU (1) YU59100A (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI265925B (en) 1999-10-11 2006-11-11 Pfizer Pyrazolo[4,3-d]pyrimidin-7-ones useful in inhibiting type 5 cyclic guanosine 3',5'-monophosphate phosphodiesterases(cGMP PDE5), process and intermediates for their preparation, their uses and composition comprising them
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera
US6809200B2 (en) * 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
JP2006219373A (ja) * 2003-06-13 2006-08-24 Daiichi Asubio Pharma Co Ltd Ｐｄｅ７阻害作用を有するピリジニルピラゾロピリミジノン誘導体
ES2343141T3 (es) * 2005-11-16 2010-07-23 F. Hoffmann-La Roche Ag Nuevo procedimiento para la preparacion de thoc.
KR101002490B1 (ko) * 2007-06-09 2010-12-17 동아제약주식회사 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
PE20140236A1 (es) * 2011-02-23 2014-03-14 Pfizer IMIDAZO[5,1-f][1,2,4]TRIAZINAS PARA EL TRATAMIENTO DE TRASTORNOS NEUROLOGICOS
UA125630C2 (uk) * 2016-11-21 2022-05-04 Адама Аган Лтд. Спосіб одержання метоксиметилпіридиндикарбоксилату

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze
CN1134442C (zh) * 1998-04-20 2004-01-14 美国辉瑞有限公司 吡唑并嘧啶酮cGMP PDE5抑制剂、其制备方法及用途及中间体
GB9823101D0 (en) * 1998-10-23 1998-12-16 Pfizer Ltd Pharmaceutically active compounds
KR100353014B1 (ko) * 1998-11-11 2002-09-18 동아제약 주식회사 발기부전 치료에 효과를 갖는 피라졸로피리미디논 화합물
YU59100A (sh) * 1999-10-11 2003-10-31 Pfizer Inc. Postupak za dobijanje pirazolo (4,3-d) pirimidin-7-ona-3-piridilsulfonil jedinjenja i njihova intermedijera

Also Published As

Publication number Publication date
EP1092720A2 (fr) 2001-04-18
YU59100A (sh) 2003-10-31
HRP20000674A2 (en) 2001-08-31
IS5654A (is) 2001-04-12
BR0004787A (pt) 2001-05-22
HUP0003979A3 (en) 2002-03-28
EG22775A (en) 2003-08-31
AU6543600A (en) 2001-04-12
GT200000169A (es) 2002-04-03
SV2002000194A (es) 2002-01-23
EA200000924A3 (ru) 2001-06-25
NO20005104L (no) 2001-04-17
TNSN00195A1 (fr) 2005-11-10
EP1092720B1 (fr) 2005-01-12
SK15052000A3 (sk) 2003-01-09
DE60017330D1 (de) 2005-02-17
KR20010050935A (ko) 2001-06-25
CN1292379A (zh) 2001-04-25
HU0003979D0 (en) 2000-12-28
AR029767A1 (es) 2003-07-16
MA25867A1 (fr) 2003-10-01
CZ20003754A3 (cs) 2002-06-12
NO20005104D0 (no) 2000-10-10
NO316072B1 (no) 2003-12-08
IL138913A0 (en) 2001-11-25
EE200000537A (et) 2001-06-15
BG104840A (bg) 2001-10-31
NZ507431A (en) 2002-09-27
CA2322995A1 (fr) 2001-04-11
IN190477B (fr) 2003-08-02
PL343140A1 (en) 2001-04-23
SG97950A1 (en) 2003-08-20
EA200000924A2 (ru) 2001-04-23
CO5251476A1 (es) 2003-02-28
KR100395718B1 (ko) 2003-08-25
PE20010682A1 (es) 2001-07-04
UY26388A1 (es) 2001-05-31
PA8504601A1 (es) 2002-02-21
ID27539A (id) 2001-04-12
EA003145B1 (ru) 2003-02-27
JP2001114783A (ja) 2001-04-24
TR200002959A2 (tr) 2001-07-23
EP1092720A3 (fr) 2001-09-19
ATE286899T1 (de) 2005-01-15
MXPA00009936A (es) 2002-10-23
OA11495A (en) 2004-05-05
HUP0003979A2 (hu) 2001-12-28

Similar Documents

Publication Publication Date Title
DZ2653A1 (fr) Procédé de préparation de dérivés de la classe destaxoïdes.
DZ3079A1 (fr) Procédé pour la préparation de 4-carboxy-amino-2-substitué-1,2,3,4 tétrahydroquinolé.
DZ3030A1 (fr) Procédé et produits intermédiaires pour la préparation de composés anti-cancéreux.
DZ2634A1 (fr) Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
HK1031869A1 (en) 1-Ä(1-Substituted-4-piperidinyl)methylÜ-4-piperdine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds.
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
DZ2963A1 (fr) Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2247A1 (fr) Procédé pour la préparation du sildénafil.
DZ712A1 (fr) Nouveaux dérivés de 2-2 iminobisethanol utiles comme médecaments, intermédiaires pour leur préparation et procédés pour la préparation de ces dérivés et intermédiaires.
DZ2457A1 (fr) Derivés de nicotinamide nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
HUP9700126A3 (en) 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazotidinone derivatives and pharmaceutical compositions containing them, process for producing the compounds and intermediates of them
DZ2217A1 (fr) Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
DZ2912A1 (fr) Procédé pour la préparation de pyrazolo Ä4,3-DÜpyrimidine-7-ones, et intermédiaires pour ce procédé.
DZ3045A1 (fr) Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2188A1 (fr) Dérivés de quinoxalinedone, procédés et intermédiaires pour leur préparation et compositions pharmaceutiques les contenant.
HK1029942A1 (en) Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma.
DZ1946A1 (fr) Procédé pour la préparation de supports.
DZ2607A1 (fr) Procédé pour la synthése de dérivés de quinoléine pharmaceutiquement actifs.
DZ2430A1 (fr) Procédé pour la préparation de dérivés de thiazolidinedione substitués.
DZ3096A1 (fr) Procédé pour la préparation de dérivés de pyrazoloÄ4,3-DÜpyrimidine-7-one-3-pyridylsulfonyle, et intermédiaires utilisés.
DZ2637A1 (fr) Procédé de production de thiazolidinediones substituées.
DZ3023A1 (fr) Dérivés de résorcinol, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ2308A1 (fr) Procédés et intermédiaires pour la préparation de dérivés de chromanol substitués.
DZ2677A1 (fr) Compositions nouvelles renfermant des dérivés de benzopyranne et pyridopyranne et procédé pour leur préparation.
FR2721598B1 (fr) Procédé de préparation de catalyseurs d'ammoxydation.